DRUG 0.96 (-11.93%)
CA10919W1086BiotechnologyBiotechnology

Bright Minds Biosciences (DRUG) Stock Highlights

0.96 | -11.93%
2024-05-01 04:18:57
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The companys drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Statistics

Range Today
0.93 1.13
Volume Today 48.4K
Range 1 Year
1.05 6.44
Volume 1 Year 45.62M
Range 3 Year
1.05 44.75
Volume 3 Year 221.4M
Range 10 Year
1.05 44.75
Volume 10 Year 221.42M

Highlights

Market Capitalization 5.42M (micro)
Floating Shares 3.18M
Current Price 0.96
Price To Earnings -0.85
Price To Book 0.81
Earnings Per Share -1.3
Payout Ratio 0%

Performance

Latest -11.93%
1 Month -21.31%
3 Months -50%
6 Months -30.43%
1 Year -70%
3 Years -95.82%
5 Years -96.33%
10 Years -96.33%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.